BioSpace News Archive

TurningPoint Healthcare Solutions unveiled today TurningPoint Digital Joint and Spine, a comprehensive musculoskeletal (MSK) management platform moving care management.

Extremity Medical, LLC announced today that it filed a lawsuit against Nextremity Solutions, Inc.; Zimmer Biomet Holdings, Inc.; and Zimmer, Inc., alleging infringement of an Extremity Medical patent* for its intraosseous fixation platform arising from the marketing of the InCore Lapidus System by these companies.

Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results for the three and 12 months ended December 31, 2021 and provides a business update.

Celsion Corporation (NASDAQ: CLSN) and Medidata, a Dassault Systèmes company, today announced that they will be presenting their findings on the use of a Synthetic Control ArmⓇ (SCA) in a completed Phase Ib dose-escalating study of GEN-1 in the neoadjuvant treatment of patients with Stage III/IV ovarian cancer (the OVATION 1 Study) at the Annual Meeting of the American Association for Cancer Research.

Day One Biopharmaceuticals announced that management will present at the 21st Annual Needham Virtual Healthcare Conference on Wednesday, April 13 at 3:45 p.m. ET.

Neuropathix, Inc., a socially responsible pain management life sciences company, announced that its CEO Dean Petkanas has issued a letter to its shareholders, providing commentary on the Company’s recently achieved milestones, updates on its research and financial positioning.

Dr. Serhat Gumrukçu, inventor and co-founder of Enochian BioSciences and Director of Research at the Seraph Research Institute, was invited to present his innovative clinical strategies to treat HIV and Cancer at the Innate Killer Summit in San Diego, California.

Propanc Biopharma, Inc. announced that its Chief Executive Officer, Mr. James Nathanielsz, expressed concern over disruption to cancer care during the global pandemic, where patients are experiencing delays to diagnoses and treatment, to halting clinical trials.

Covestro, a leading polymer company, is proud to announce its collaboration with PharmaJet, a leading biotech company in needle-free injection technology.

HitGen Inc. (“HitGen”), a Shanghai Stock Exchange STAR-listed company (ticker code 688222.SH), today announced that the company has successfully completed the multiple-target drug discovery research projects with UPPTHERA, a Korean pharmaceutical company aiming for new drug development employing “Protein Degradation Technology”.